The discrepancy in response to blocking IL-17A has also been explained by Park et al., who have shown that Il-17a–/– T cell transfer and αIL-17A treatment can attenuate acute colitis and not chronic colitis (40). This evidence concerns the gene IL17A and Chronic colitis.